Tolerance engineering in Deinococcus geothermalis by heterologous efflux pumps.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 02 2021
Historique:
received: 02 07 2020
accepted: 28 01 2021
entrez: 20 2 2021
pubmed: 21 2 2021
medline: 15 12 2021
Statut: epublish

Résumé

Producing industrially significant compounds with more environmentally friendly represents a challenging task. The large-scale production of an exogenous molecule in a host microfactory can quickly cause toxic effects, forcing the cell to inhibit production to survive. The key point to counter these toxic effects is to promote a gain of tolerance in the host, for instance, by inducing a constant flux of the neo-synthetized compound out of the producing cells. Efflux pumps are membrane proteins that constitute the most powerful mechanism to release molecules out of cells. We propose here a new biological model, Deinococcus geothermalis, organism known for its ability to survive hostile environment; with the aim of coupling the promising industrial potential of this species with that of heterologous efflux pumps to promote engineering tolerance. In this study, clones of D. geothermalis containing various genes encoding chromosomal heterologous efflux pumps were generated. Resistant recombinants were selected using antibiotic susceptibility tests to screen promising candidates. We then developed a method to determine the efflux efficiency of the best candidate, which contains the gene encoding the MdfA of Salmonella enterica serovar Choleraesuis. We observe 1.6 times more compound in the external medium of the hit recombinant than that of the WT at early incubation time. The data presented here will contribute to better understanding of the parameters required for efficient production in D. geothermalis.

Identifiants

pubmed: 33608597
doi: 10.1038/s41598-021-83339-1
pii: 10.1038/s41598-021-83339-1
pmc: PMC7896070
doi:

Substances chimiques

Anti-Bacterial Agents 0
Membrane Transport Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4280

Références

J Appl Microbiol. 2011 Apr;110(4):851-61
pubmed: 21332616
Can J Microbiol. 1978 Feb;24(2):162-76
pubmed: 647473
Mol Microbiol. 2006 Jan;59(1):126-41
pubmed: 16359323
Science. 2017 Jan 6;355(6320):
pubmed: 28059717
PLoS One. 2007 Sep 26;2(9):e955
pubmed: 17895995
Clin Microbiol Rev. 2015 Apr;28(2):337-418
pubmed: 25788514
Astrobiology. 2017 May;17(5):431-447
pubmed: 28520474
Biochim Biophys Acta. 2015 Dec;1848(12):3181-7
pubmed: 26450150
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
FEMS Microbiol Lett. 2008 Sep;286(2):227-35
pubmed: 18647360
J Biol Chem. 2005 Mar 25;280(12):11422-31
pubmed: 15640151
Nat Microbiol. 2017 Feb 22;2:17001
pubmed: 28224989
Appl Microbiol Biotechnol. 2015 Dec;99(24):10539-46
pubmed: 26311221
Front Microbiol. 2016 Feb 16;7:155
pubmed: 26909071
J Bacteriol. 2001 May;183(10):3169-75
pubmed: 11325946
Antimicrob Agents Chemother. 2016 Mar 25;60(4):1974-83
pubmed: 26824939
Arch Mikrobiol. 1965 Jul 20;51(3):267-89
pubmed: 5882498
Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13953-8
pubmed: 18768810
J Bacteriol. 2012 Mar;194(6):1552-61
pubmed: 22228732
Mol Microbiol. 1999 Jun;32(5):893-906
pubmed: 10361294
Trends Microbiol. 2015 Aug;23(8):498-508
pubmed: 26024777
J Bacteriol. 2002 Nov;184(22):6182-9
pubmed: 12399488
J Appl Microbiol. 2015 Jul;119(1):1-10
pubmed: 25809882
Appl Environ Microbiol. 2003 Aug;69(8):4575-82
pubmed: 12902245
Anal Chem. 2015 Apr 7;87(7):3579-84
pubmed: 25753586
Science. 1977 Nov 18;198(4318):679-84
pubmed: 333584
Nat Protoc. 2018 Jun;13(6):1348-1361
pubmed: 29773906
Mol Biosyst. 2010 Oct;6(10):2068-77
pubmed: 20714501
Res Microbiol. 2018 Sep - Oct;169(7-8):363-371
pubmed: 29577985
Chem Rev. 2018 Jan 10;118(1):4-72
pubmed: 28443658
Microbiol Rev. 1987 Jun;51(2):221-71
pubmed: 2439888
J Antimicrob Chemother. 2019 Jan 1;74(1):58-65
pubmed: 30325444
Nat Rev Microbiol. 2018 Sep;16(9):523-539
pubmed: 30002505
Res Microbiol. 2018 Sep - Oct;169(7-8):432-441
pubmed: 29208490
Mol Syst Biol. 2011 May 10;7:487
pubmed: 21556065
Antonie Van Leeuwenhoek. 2011 Aug;100(2):171-82
pubmed: 21717204
Nat Biotechnol. 2006 Aug;24(8):997-1004
pubmed: 16878126
Trends Biotechnol. 2016 Aug;34(8):652-664
pubmed: 26996613
World J Microbiol Biotechnol. 2017 Jun;33(6):112
pubmed: 28470425
Sci Rep. 2017 Apr 06;7:45929
pubmed: 28383523
Int J Syst Bacteriol. 1997 Oct;47(4):939-47
pubmed: 9336890
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
J Bacteriol. 2017 Dec 5;200(1):
pubmed: 29038251
J Bacteriol. 1999 Jan;181(1):334-7
pubmed: 9864347
FEMS Microbiol Rev. 2012 Mar;36(2):340-63
pubmed: 21707670
Microbiology (Reading). 2006 Sep;152(Pt 9):2779-2787
pubmed: 16946272
Microbiol Mol Biol Rev. 1998 Dec;62(4):1435-91
pubmed: 9841678

Auteurs

Erika Boulant (E)

Aix Marseille Univ, INSERM, SSA, IRBA, MCT, Marseille, France.
Deinove, Cap Sigma/ZAC Euromédecine II, Grabels, France.

Emmanuelle Cambon (E)

Deinove, Cap Sigma/ZAC Euromédecine II, Grabels, France.

Julia Vergalli (J)

Aix Marseille Univ, INSERM, SSA, IRBA, MCT, Marseille, France.

Rémi Bernard (R)

Deinove, Cap Sigma/ZAC Euromédecine II, Grabels, France.
Vilmorin SA, Centre de Recherche de La Costière, Ledenon, France.

Fabienne Neulat-Ripoll (F)

Institut de Recherche Biomédicale des Armées, Département Microbiologie et Maladies Infectieuses, Unité Bactériologie, Brétigny-sur-Orge, France.

Flora Nolent (F)

Institut de Recherche Biomédicale des Armées, Département Microbiologie et Maladies Infectieuses, Unité Bactériologie, Brétigny-sur-Orge, France.

Olivier Gorgé (O)

Institut de Recherche Biomédicale des Armées, Département Microbiologie et Maladies Infectieuses, Unité Bactériologie, Brétigny-sur-Orge, France.

Maria Girleanu (M)

Institut de Recherche Biomédicale des Armées, Département des Plateformes et Recherche Technologique, Unité Imagerie, Brétigny-sur-Orge, France.

Anne-Laure Favier (AL)

Institut de Recherche Biomédicale des Armées, Département des Plateformes et Recherche Technologique, Unité Imagerie, Brétigny-sur-Orge, France.

Jean-Paul Leonetti (JP)

Deinove, Cap Sigma/ZAC Euromédecine II, Grabels, France.
Institut de Recherche en Infectiologie de Montpellier, UMR 9004-CNRS/UM, Montpellier, France.

Jean Michel Bolla (JM)

Aix Marseille Univ, INSERM, SSA, IRBA, MCT, Marseille, France. jean-michel.bolla@univ-amu.fr.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Coal Metagenome Phylogeny Bacteria Genome, Bacterial
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Classifications MeSH